{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T18:15:24Z","timestamp":1785089724603,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vaccine.2023.07.026","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T01:55:13Z","timestamp":1689818113000},"page":"5392-5399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial"],"prefix":"10.1016","volume":"41","author":[{"given":"Tilda","family":"Orami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine","family":"Aho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Pomat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Greenhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5421-8126","authenticated-orcid":false,"given":"Lea-Ann","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Masiria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birunu","family":"Nivio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-8293","authenticated-orcid":false,"given":"Kathryn J.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita H.J.","family":"van den Biggelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.07.026_b0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Lower Respiratory Infections Collaborators","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study","volume":"16","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0020","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0140-6736(18)33005-8","article-title":"Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study","volume":"393","author":"Hammitt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.07.026_b0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0377","article-title":"Efficacy and effectiveness of the PCV-10 and PCV-13 vaccines against invasive pneumococcal disease","volume":"145","author":"Berman-Rosa","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.07.026_b0030","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia and hospitalisation in Eastern Highlands Province, Papua New Guinea: An observational cohort study","volume":"22","author":"Blyth","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2023.07.026_b0035","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/INF.0000000000000083","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage","volume":"33","author":"Fleming-Dutra","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.07.026_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vacrep.2016.08.002","article-title":"Limited impact of neonatal or early infant schedules of 7-valent pneumooccal conjugate vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in Papua New Guinean children: A randomized controlled trial","volume":"6","author":"Aho","year":"2016","journal-title":"Vaccine Reports"},{"key":"10.1016\/j.vaccine.2023.07.026_b0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cir444","article-title":"Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection","volume":"53","author":"Scott","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijid.2020.06.048","article-title":"Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction","volume":"98","author":"Njuma Libwea","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0055","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s41467-020-15786-9","article-title":"High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi","volume":"11","author":"Swarthout","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.07.026_b0060","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/jiab037","article-title":"Pneumococcal carriage in Burkina Faso after 13-valent pneumococcal conjugate vaccine introduction: Results from 2 cross-sectional population-based surveys","volume":"224","author":"Kabor\u00e9","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2021.11.021","article-title":"Pneumococcal carriage among children in low and lower-middle-income countries: A systematic review","volume":"115","author":"Tvedskov","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(08)70281-0","article-title":"Impact of conjugate pneumococcal vaccines on antibiotic resistance","volume":"8","author":"Dagan","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2023.07.026_b0080","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/14760584.2019.1676155","article-title":"The impact of routine childhood immunisation with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review","volume":"18","author":"Tin Tin Htar","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.07.026_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7774\/cevr.2021.10.2.81","article-title":"Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2021","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2023.07.026_b0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2023.07.026_b0095","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1080\/21645515.2019.1710411","article-title":"Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogot\u00e1, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10","volume":"16","author":"Camacho Moreno","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.07.026_b0100","doi-asserted-by":"crossref","first-page":"e56698","DOI":"10.1371\/journal.pone.0056698","article-title":"Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial","volume":"8","author":"Pomat","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.07.026_b0105","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/cid\/ciy743","article-title":"Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants","volume":"68","author":"Pomat","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0110","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/CVI.00247-09","article-title":"Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants","volume":"16","author":"Francis","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 8","key":"10.1016\/j.vaccine.2023.07.026_b0115","doi-asserted-by":"crossref","first-page":"S1006","DOI":"10.1093\/clinids\/12.Supplement_8.S1006","article-title":"Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea","volume":"12","author":"Montgomery","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0120","unstructured":"Aho C, Binks M, Michael A, Yoannes M, Greenhill A, Pomat W, et al. Pneumococcal antibiotic susceptibility patterns and nasopharyngeal bacterial carriage in Papua New Guinean infants vaccinated with a 7-valent pneumococcal conjugate vaccine (7vPCV). In: 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11). Melbourne, Australia: Kenes; 2018. p. 419."},{"key":"10.1016\/j.vaccine.2023.07.026_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41479-017-0044-z","article-title":"Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea","volume":"9","author":"Lehmann","year":"2017","journal-title":"Pneumonia"},{"key":"10.1016\/j.vaccine.2023.07.026_b0130","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1016\/j.vaccine.2021.07.085","article-title":"Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants","volume":"39","author":"Britton","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.026_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/vaccines7010017","article-title":"Immunogenicity and immune memory after a pneumococcal polysaccharide vaccine booster in a high-risk population primed with 10-valent or 13-valent pneumococcal conjugate vaccine: a randomized controlled trial in Papua New Guinean Children","volume":"7","author":"van den Biggelaar","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.07.026_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.026_b0145","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute; 2011."},{"key":"10.1016\/j.vaccine.2023.07.026_b0150","unstructured":"Papua New Guinea: WHO and UNICEF estimates of immunization coverage: 2021 revision. 2021. Available from: https:\/\/www.who.int\/publications\/m\/item\/immunization-png-2022-country profile."},{"key":"10.1016\/j.vaccine.2023.07.026_b0155","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3201\/eid2306.170071","article-title":"Invasive serotype 35B pneumococci including an expanding serotype switch lineage, United States, 2015\u20132016","volume":"23","author":"Chochua","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.744742","article-title":"Transition of serotype 35B pneumococci from commensal to prevalent virulent strain in children","volume":"11","author":"Fuji","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2023.07.026_b0165","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/00365540510035346","article-title":"Dynamics of pneumococcal carriage among healthy Icelandic children attending day-care centres","volume":"37","author":"Tomasson","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0170","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/j.vaccine.2019.07.077","article-title":"Stable dynamics of pneumococcal carriage over a decade in the pre-PCV era","volume":"37","author":"Wagner","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.026_b0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.3.5876.405-a","article-title":"Pneumococci with increased resistance to penicillin","volume":"3","author":"Hansman","year":"1973","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.07.026_b0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00006454-199703000-00009","article-title":"Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci","volume":"16","author":"Lehmann","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.07.026_b0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12879-015-1197-0","article-title":"Streptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era","volume":"15","author":"Greenhill","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.026_b0190","unstructured":"Standard Treatment for Common Illnesses of Children in Papua New Guinea. A manual for nurses, community health workers, health extension officers, and doctors. Port Moresby; 2016. Available from: http:\/\/pngpaediatricsociety.org\/wp-content\/uploads\/2016\/11\/PNG-Standard-Treatment-Book-10th-edition-2016.pdf."},{"issue":"7","key":"10.1016\/j.vaccine.2023.07.026_b0195","first-page":"mgen000835","article-title":"Distinct Streptococcus pneumoniae cause invasive disease in Papua New Guinea","volume":"8","author":"Mellor","year":"2022","journal-title":"Microb Genom"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:29:14Z","timestamp":1759404554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23008381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0264410X23008381"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}